Trial Profile

A Open-label, Single Center Drug Interaction Study Between HEC74647PA Capsule and HEC110114 in Healthy Subjects

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 22 Feb 2021

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Encofosbuvir (Primary) ; Netanasvir phosphate (Primary)
Indications Hepatitis C
Focus Adverse reactions; Pharmacokinetics
Sponsors Sunshine Lake Pharma

Most Recent Events

04 Nov 2020 Status changed from recruiting to completed.
29 Jul 2020 Planned primary completion date changed from 30 Jul 2020 to 30 Aug 2020.
29 Jul 2020 Status changed from not yet recruiting to recruiting.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com